| ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES |
|---|
| (a) | LIST OF DOCUMENTS FILED AS PART OF THIS REPORT: |
|---|
The financial statements and notes thereto, and the report of the independent registered public accounting firm thereon, are set forth on pages F-1 through F-34.
| 2. | Financial Statement Schedules |
All financial statement schedules have been omitted as the information is not required under the related instructions or is not applicable or because the information required is already included in the financial statements or the notes to those financial statements.
| | | | | | | | | | | | | |
|---|
| Exhibit · · · · Incorporated by Reference · · Filed |
|---|
| Number | | Exhibit Description | | Form | | File No. | | Exhibit | | Filing Date | | Herewith |
|---|
| 3.1 | | Fourth Amended and Restated Certificate of Incorporation of Aspira Women’s Health Inc. dated January 22, 2010 | | 8-K | | 000-31617 | | 3.1 | | January 25, 2010 | | |
| 3.2 | | Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation, effective June 19, 2014 | | 10-Q | | 001-34810 | | 3.2 | | August 14, 2014 | | |
| 3.3 | | Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation of Vermillion, Inc. dated June 11, 2020 | | 8-K | | 001-34810 | | 3.1 | | June 11, 2020 | | |
| 3.4 | | Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation of Aspira Women’s Health Inc, dated February 7, 2023 | | 8-K | | 001-34810 | | 3.1 | | February 7, 2023 | | |
| 3.5 | | Amended and Restated Bylaws of Aspira Women’s Health Inc., effective March 28, 2025 | | 8-K | | 001-34810 | | 3.1 | | March 31, 2025 | | |
| 3.6 | | Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Aspira Women’s Health Inc., as amended May 11, 2023 | | 8-K | | 001-34810 | | 3.1 | | May 11, 2023 | | |
| 4.1 | | Form of Aspira Women’s Health Inc.’s (formerly Ciphergen Biosystems, Inc.) Common Stock Certificate | | S-1/A | | 333-32812 | | 4.1 | | August 24, 2000 | | |
| 4.2 | | Securities Purchase Agreement dated May 8, 2013, by and among Aspira Women’s Health Inc. (formerly Vermillion, Inc.) and the purchasers identified therein | | 8-K | | 001-34810 | | 10.1 | | May 14, 2013 | | |
| 4.3 | | Stockholders Agreement dated May 13, 2013, by and among Vermillion, Inc., Oracle Partners, LP, Oracle Ten Fund Master, LP, Jack W. Schuler and other purchasers named therein | | 8-K | | 001-34810 | | 10.2 | | May 14, 2013 | | |
| 4.4 | | Amended and Restated Promissory Note #1 by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development, effective April 3, 2020 | | 10-K | | 001-34810 | | 4.4 | | April 7, 2020 | | |
| 4.5 | | Amended and Restated Promissory Note #2 by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development, effective April 3, 2020 | | 10-K | | 001-34810 | | 4.5 | | April 7, 2020 | | |
| 4.6 | | Description of Aspira Women’s Health Inc.’s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 | | 10-K | | 001-34810 | | 4.7 | | April 1, 2024 | | |
| 4.7 | | Form of Warrant 2022 | | 8-K | | 001-34810 | | 4.1 | | August 24, 2022 | | |
| 4.8 | | Form of Warrant Amendment to Common Stock Purchase Warrant_2022 | | 8-K | | 001-34810 | | 4.3 | | January 26, 2024 | | |
| 4.9 | | Form of Warrant 2024 | | 8-K | | 001-34810 | | 4.2 | | January 26, 2024 | | |
| 4.10 | | Form of Warrant June 2024 | | 8-K | | 001-34810 | | 4.1 | | July 2, 2024 | | |
| 4.11 | | Form of Warrant July 2024 | | 8-K | | 001-34810 | | 4.1 | | July 31, 2024 | | |
| 4.12 | | Form of Warrant Amendment to Common Stock Purchase Warrant June 2024 | | 10-K | | 001-34810 | | 4.14 | | March 27, 2025 | | |
| 4.13 | | Form of Senior Convertible Note | | 8-K | | 001-34810 | | 4.1 | | March 11, 2025 | | |
| 4.14 | | Form of Warrant March 2025 | | 8-K | | 001-34810 | | 4.2 | | March 11, 2025 | | |
| 4.15 | | Form of Warrant September 2025 | | 8-K | | 001-34810 | | 4.1 | | September 25, 2025 | | |
| 4.16 | | Form of Amended and Restated Warrant, issued September 19, 2025 | | 8-K/A | | 001-34810 | | 4.1 | | November 3, 2025 | | |
| 10.1 | | Form of Aspira Women’s Health Inc Stock Option Award Agreement # | | 10-Q | | 001-34810 | | 10.4 | | August 10, 2022 | | |
| 10.2 | | Form of Aspira Women’s Health Inc Restricted Stock Award Agreement # | | 10-Q | | 001-34810 | | 10.5 | | August 10, 2022 | | |
| 10.3 | | Aspira Women’s Health Inc. 2019 Stock Incentive Plan # | | 10-Q | | 001-34810 | | 10.3 | | August 10, 2022 | | |
| 10.4 | | Form of Aspira Women’s Health Inc. Stock Option Award Agreement (non-employee) # | | 10-Q | | 001-34810 | | 10.7 | | August 10, 2022 | | |
| 10.5 | | Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion, Inc. effective March 22, 2016 | | 10-Q | | 001-34810 | | 10.1 | | May 16, 2016 | | |
| 10.6 | | Patent Security Agreement by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development, effective March 22, 2016 | | 10-Q | | 001-34810 | | 10.3 | | May 16, 2016 | | |
| 10.7 | | Security Agreement by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development, effective March 22, 2016 | | 10-Q | | 001-34810 | | 10.4 | | May 16, 2016 | | |
| 10.8 | | First Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion, Inc. dated March 7, 2018 | | 10-K | | 001-34810 | | 10.21 | | March 13, 2018 | | |
| 10.9 | | Second Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion, Inc. dated April 3, 2020 | | 10-K | | 001-34810 | | 10.22 | | April 7, 2020 | | |
| 10.10 | | License Agreement between Aspira Women’s Health Inc. and Dana-Farber Cancer Institute, Inc. effective March 20, 2023 | | 10-K | | 001-34810 | | 10.28 | | April 1, 2024 | | |
| 10.11 | | Form of Securities Purchase Agreement June 2024 | | 8-K | | 001-34810 | | 10.1 | | July 2, 2024 | | |
| 10.12 | | Form of Warrant Inducement Agreement June 2024 | | 8-K | | 001-34810 | | 10.1 | | July 31, 2024 | | |
| 10.13 | | Employment Agreement between Aspira Women’s Health Inc. and Michael Buhle effective March 26, 2025# | | 8-K | | 001-34810 | | 10.1 | | March 31, 2025 | | |
| 10.14 | | Form of Securities Purchase Agreement | | 8-K | | 001-34810 | | 10.1 | | March 11, 2025 | | |
| 10.15 | | Equity Purchase Agreement dated April 4, 2025 | | 8-K | | 001-34810 | | 10.1 | | April 8, 2025 | | |
| 10.16 | | Master Services Agreement between Aspira Women’s Health Inc. and Brian Hungerford, dated September 2, 2025 #† | | 8-K | | 001-34810 | | 10.1 | | September 3, 2025 | | |
| 10.17 | | Statement of Work by and between Aspira Women’s Health Inc. and Brian Hungerford, dated September 2, 2025 | | 8-K | | 001-34810 | | 10.2 | | September 3, 2025 | | |
| 10.18 | | Form of Securities Purchase Agreement, dated September 19, 2025 | | 8-K | | 001-34810 | | 10.1 | | September 18, 2025 | | |
| 10.19 | | Form of Amendment to Securities Purchase Agreement, dated September 19, 2025 | | 8-K | | 001-34810 | | 10.1 | | September 25, 2025 | | |
| 10.20 | | Laboratory Services Agreement between Aspira Women’s Health Inc and Mayo Collaborative Services, Inc., dated December 16, 2025 | | 8-K/A | | 001-34810 | | 10.1 | | March 25, 2026 | | |
| 10.21 | | Purchase Agreement, dated December 23, 2025, by and between Aspira Women’s Health Inc and Lincoln Park Capital Fund, LLC. | | 8-K | | 001-34810 | | 10.1 | | December 23, 2025 | | |
| 10.22 | | Registration Rights Agreement, dated December 23, 2025, by and between Aspira Women’s Health Inc and Lincoln Park Capital Fund, LLC. | | 8-K | | 001-34810 | | 10.2 | | December 23, 2025 | | |
| 10.23 | | Subordinated Business Loan and Security Agreement, dated as of January 30, 2026. | | 8-K | | 001-34810 | | 10.1 | | January 30, 2026 | | |
| 10.24 | | Form of Subordinated Secured Promissory Note | | 8-K | | 001-34810 | | 10.2 | | January 30, 2026 | | |
| 19.1 | | Aspira Women’s Health Inc. Insider Trading Policy | | 10-K | | 001-34810 | | 19.1 | | March 27, 2025 | | |
| 21.0 | | Subsidiaries of Registrant | | 10-K | | 001-34810 | | 21.0 | | March 31, 2022 | | |
| 23.1 | | Consent of BDO USA, P.C., Independent Registered Public Accounting Firm | | | | | | | | | | √ |
| 24.1 | | Power of Attorney (included on signature page hereto) | | | | | | | | | | √ |
| 31.1 | | Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | | | | | | | | | √ |
| 31.2 | | Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | | | | | | | | | √ |
| 32.1 | | Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | | | | | | | | | √ |
| 97.1 | | Aspira Women’s Health Incentive Compensation Recoupment Policy | | 10-K | | 001-34810 | | 97.1 | | March 29, 2024 | | |
| 101 | | Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline Extensible Business Reporting Language (“Inline XBRL”) | | | | | | | | | | |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | | | | | | | | | | |
| # | Management contract or compensatory plan or arrangement. |
|---|
| † | Confidential treatment has been granted with respect to certain provisions of this agreement. Omitted portions have been filed separately with the SEC. |
|---|
